Podcast Episodes
Back to Search
Everyday Exposures to Parkinson’s: Environmental Connections to the Disease (Webinar Audio)
The biology behind what causes Parkinson’s is complex, with only about a quarter of cases with clear genetic drivers. The environment – where you liv…
2 years, 1 month ago
The Importance of Sex and Gender Factors in Neurodegenerative Disease Research and Care with Antonella Santuccione Chadha
Increasing evidence supports the presence of sex and gender differences in neurodegenerative conditions, including Alzheimer's disease and Parkinson'…
2 years, 2 months ago
Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris
Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and de…
2 years, 2 months ago
Therapies for Tomorrow: How Better Clinical Trial Design Leads to Better Treatments (Webinar Audio)
The drug development pipeline is key to bringing new therapies to people with Parkinson’s disease (PD). With major breakthroughs in research in the p…
2 years, 2 months ago
Examining the Proposed Biological Definition of Neuronal Alpha-Synuclein Disease and Staging System with Lana Chahine
For many years, Parkinson's disease and dementia with Lewy bodies have been defined using clinical features. With recent advances in biomarkers, part…
2 years, 3 months ago
Dating and New Relationships after a Parkinson’s Diagnosis
Dating and beginning new relationships with Parkinson’s involve distinct challenges, joys and fears. In this frank and funny podcast, our experts dis…
2 years, 3 months ago
Managing Risk for Drug Discovery and Development in Parkinson's Disease with Kalpana Merchant
There is a pressing need to develop safe and effective disease-modifying and symptomatic treatments for Parkinson's disease. Through improvements in …
2 years, 3 months ago
New Year, New Moves! Explore Exercise for Life with Parkinson’s (Webinar Audio)
We know exercise is important for people with Parkinson’s. Once you’ve decided to move more, what next? In this audio from our Third Thursdays Webina…
2 years, 3 months ago
How MJFF “De-Risks” PD Drug Development Pipeline
One key pillar of The Michael J. Fox Foundation’s research strategy is a focus on “de-risking" potential treatments for Parkinson’s disease. This epi…
2 years, 4 months ago
Using Neuroimaging and Biomarkers to Improve Neurodegenerative Disease Diagnosis and Assessment with John Seibyl
In neurodegenerative conditions such as Parkinson's disease (PD), patients often do not receive a diagnosis until the hallmark motor symptoms begin t…
2 years, 4 months ago